Skip to main content
Erschienen in: Neurosurgical Review 4/2020

22.06.2019 | Original Article

Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model

verfasst von: M. Barbot, F. Ceccato, L. Lizzul, A. Daniele, M. Zilio, M. P. Gardiman, L. Denaro, E. Emanuelli, F. Vianello, G. Lombardi, G. Rolma, C. Scaroni, Padova Pituitary Club

Erschienen in: Neurosurgical Review | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Perioperative management of patients with sellar lesion submitted to endoscopic transsphenoidal neurosurgery (TSS) lacks standardization and therefore it is committed to each center clinical practice. Although neurosurgical procedure remains the same for all sellar lesions, perioperative approach can require different measures depending on the underlying disease. With the aim of standardizing our perioperative procedures and sharing our experience with other centers involved in the management of pituitary disease, we developed a clinical care path for patients with sellar lesions candidate to endoscopic TSS. For the drafting of the following protocol, the national and international guidelines published in the last 5 years have been evaluated and integrated with our center experience accumulated in decades of clinical practice. A steering committee including medical doctors involved in management of patients with pituitary masses at the Padua Hospital reviewed current knowledge on this topic. The committee developed a first draft which was shared with a broader group of medical doctors to reach a preliminary consensus; when it was reached, the clinical care assistance pathway was confirmed, validated, and published in the local web-based health service. We want to present and share our experience with colleagues involved in the perioperative management of pituitary diseases in other centers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91(12):4769–4775CrossRefPubMed Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91(12):4769–4775CrossRefPubMed
4.
Zurück zum Zitat Freda PU, Post KD (1999) Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am 28(1):81–117 vi CrossRef Freda PU, Post KD (1999) Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am 28(1):81–117 vi CrossRef
5.
Zurück zum Zitat Wagenmakers MA, Boogaarts HD, Roerink SH, Timmers HJ, Stikkelbroeck NM, Smit JW, van Lindert EJ, Netea-Maier RT, Grotenhuis JA, Hermus AR (2013) Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing’s disease, even in case of macroadenomas or invasive adenomas. Eur J Endocrinol 169(3):329–337. https://doi.org/10.1530/EJE-13-0325 CrossRefPubMed Wagenmakers MA, Boogaarts HD, Roerink SH, Timmers HJ, Stikkelbroeck NM, Smit JW, van Lindert EJ, Netea-Maier RT, Grotenhuis JA, Hermus AR (2013) Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing’s disease, even in case of macroadenomas or invasive adenomas. Eur J Endocrinol 169(3):329–337. https://​doi.​org/​10.​1530/​EJE-13-0325 CrossRefPubMed
6.
Zurück zum Zitat Ben-Shlomo A, Melmed S (2003) Clinical review 154: the role of pharmacotherapy in perioperative management of patients with acromegaly. J Clin Endocrinol Metab 88(3):963–968CrossRefPubMed Ben-Shlomo A, Melmed S (2003) Clinical review 154: the role of pharmacotherapy in perioperative management of patients with acromegaly. J Clin Endocrinol Metab 88(3):963–968CrossRefPubMed
8.
Zurück zum Zitat Inder WJ, Alford FP (2007) Pituitary masses: the importance of a multidisciplinary approach. Med J Aust 187(9):522–523CrossRefPubMed Inder WJ, Alford FP (2007) Pituitary masses: the importance of a multidisciplinary approach. Med J Aust 187(9):522–523CrossRefPubMed
12.
14.
Zurück zum Zitat Grilli R, Magrini N, Penna A, Mura G, Liberati A (2000) Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 355(9198):103–106CrossRefPubMed Grilli R, Magrini N, Penna A, Mura G, Liberati A (2000) Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 355(9198):103–106CrossRefPubMed
19.
Zurück zum Zitat Hammarstrand C, Ragnarsson O, Hallén T, Andersson E, Skoglund T, Nilsson AG, Johannsson G (2017) Olsson DS (2017) higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma. Eur J Endocrinol 177(3):251–256. https://doi.org/10.1530/EJE-17-0340 CrossRefPubMed Hammarstrand C, Ragnarsson O, Hallén T, Andersson E, Skoglund T, Nilsson AG, Johannsson G (2017) Olsson DS (2017) higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma. Eur J Endocrinol 177(3):251–256. https://​doi.​org/​10.​1530/​EJE-17-0340 CrossRefPubMed
20.
Zurück zum Zitat Loh JA, Verbalis JG (2007) Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab 3(6):489–494CrossRefPubMed Loh JA, Verbalis JG (2007) Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab 3(6):489–494CrossRefPubMed
21.
Zurück zum Zitat Woodmansee WW, Carmichael J, Kelly D, Katznelson L, AACE (2015) Neuroendocrine and Pituitary Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: postoperative management following pituitary surgery. Endocr Pract 21(7):832–838. https://doi.org/10.4158/EP14541.DSCR CrossRefPubMed Woodmansee WW, Carmichael J, Kelly D, Katznelson L, AACE (2015) Neuroendocrine and Pituitary Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: postoperative management following pituitary surgery. Endocr Pract 21(7):832–838. https://​doi.​org/​10.​4158/​EP14541.​DSCR CrossRefPubMed
22.
Zurück zum Zitat Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van den Berg G, Pereira AM, de Herder WW, Wagenmakers MA, Kerstens MN, Zelissen PM, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerdes VE (2011) Incidence of venous thromboembolism in patients with Cushing’s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96(11):3525–3532. https://doi.org/10.1210/jc.2011-1661 CrossRefPubMed Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van den Berg G, Pereira AM, de Herder WW, Wagenmakers MA, Kerstens MN, Zelissen PM, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerdes VE (2011) Incidence of venous thromboembolism in patients with Cushing’s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96(11):3525–3532. https://​doi.​org/​10.​1210/​jc.​2011-1661 CrossRefPubMed
23.
Zurück zum Zitat Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing’s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163(5):783–791. https://doi.org/10.1530/EJE-10-0583 CrossRefPubMed Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing’s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163(5):783–791. https://​doi.​org/​10.​1530/​EJE-10-0583 CrossRefPubMed
25.
Zurück zum Zitat Dumont AS, Nemergut EC 2nd, Jane JA Jr, Laws ER Jr (2005) Postoperative care following pituitary surgery. J Intensive Care Med 20(3):127–140CrossRefPubMed Dumont AS, Nemergut EC 2nd, Jane JA Jr, Laws ER Jr (2005) Postoperative care following pituitary surgery. J Intensive Care Med 20(3):127–140CrossRefPubMed
27.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD, Cavenne C (Eds) (2016) WHO classification of tumours of the central nervous system. Revised 4th edition. IARC: Lyon Louis DN, Ohgaki H, Wiestler OD, Cavenne C (Eds) (2016) WHO classification of tumours of the central nervous system. Revised 4th edition. IARC: Lyon
28.
Zurück zum Zitat Lloyd RV, Kovacs K, Young WFJ, Farrell WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW, E H (2004) Pituitary tumours: introduction. In chaper 1: Tumours of the pituitary. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours - Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp 10–13 Lloyd RV, Kovacs K, Young WFJ, Farrell WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW, E H (2004) Pituitary tumours: introduction. In chaper 1: Tumours of the pituitary. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours - Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp 10–13
Metadaten
Titel
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model
verfasst von
M. Barbot
F. Ceccato
L. Lizzul
A. Daniele
M. Zilio
M. P. Gardiman
L. Denaro
E. Emanuelli
F. Vianello
G. Lombardi
G. Rolma
C. Scaroni
Padova Pituitary Club
Publikationsdatum
22.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Neurosurgical Review / Ausgabe 4/2020
Print ISSN: 0344-5607
Elektronische ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-019-01132-1

Weitere Artikel der Ausgabe 4/2020

Neurosurgical Review 4/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.